Skip to main content

olmesartan medoxomil

NDC 16729-320 · Accord Healthcare Inc.

Generic nameolmesartan medoxomil
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL
Strength5 mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
Marketing categoryANDA

Packages

16729-320-10 — 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-320-10)

16729-320-15 — 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-320-15)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0713-0875 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 0713-0876 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 0713-0877 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 0713-0878 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 0713-0940 — olmesartan medoxomil, 0713-0941 — olmesartan medoxomil, 0713-0942 — olmesartan medoxomil, 0713-0943 — olmesartan medoxomil-hydrochlorothiazide, 0713-0944 — olmesartan medoxomil-hydrochlorothiazide, 0713-0945 — olmesartan medoxomil-hydrochlorothiazide, 16729-321 — olmesartan medoxomil, 16729-322 — olmesartan medoxomil, 16729-366 — OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, 16729-367 — OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, 16729-368 — OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, 27241-083 — Amlodipine besylate and Olmesartan medoxomil, 27241-084 — Amlodipine besylate and Olmesartan medoxomil, 27241-085 — Amlodipine besylate and Olmesartan medoxomil, 27241-086 — Amlodipine besylate and Olmesartan medoxomil, 31722-445 — Amlodipine and Olmesartan Medoxomil, +281 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels